1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NECTAR LIFESCIENCES LTD.
Nectar Lifesciences Ltd.
NSE: NECLIFE | BSE: 532649

Nectar Lifesciences Live Share Price Today, Share Analysis and Chart

Expensive Underperformer
about

Nectar Lifesciences Ltd. (NecLife) is an Indian pharmaceutical company primarily focused on the manufacturing and global supply of Cephalosporin Active Pharmaceutical Ingredients (APIs) and Finished Dosage Formulations (FDF). The company operates...

Read More
Iran War Impact
Ask MarketMind AI
11.98 0.00 (0.00%)
53.02% Fall from 52W High
206.7K
NSE+BSE Volume

NSE 05 Jun, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
Medium Financial Strength
- / 100
Valuation Score
Expensive Valuation
- / 100
Momentum Score
Technically Bearish
29.8 / 100
Expensive Underperformer These stocks have average quality, expensive valuations and weak momentum. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
No estimates available

7

S

16

W

1

O

0

T

SWOT Analysis

Nectar Lifesciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Nectar Lifesciences Ltd. worth buying?
176 Votes:
Buy 78.41%
Sell 16.48%
Hold 5.11%
BUY
SELL
HOLD
Ask AI
×